References
- Bonelli J., Hitzenberger G., Krause W., Wendt H., Speck U. Pharmacokinetics and pharmacodynamics of mepindolol sulphate. International Journal of Clinical Pharmacology, Therapeutics and Toxicology 1980; 18: 169–176
- Kehr W., Debus G., Neumeister R. Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brain. Journal of Neural Transmission 1985; 63: 1–12
- Przegalinski E., Bigajska K., Lewandowska A. The influence of rolipram in the central serotoninergic system. Pharmacopsychiat 1981; 14: 162–166
- Schmidt B., Volk R., Schultz J. E. Induction of enteral noradrenergic subsensitivity after long-term treatment of rats with rolipram. Naunyn Schmiedeberg's Arch. Pharmacol 1985; 329: R92, (Suppl.)
- Wachtel H. Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors. Psychopharmacology 1982; 77: 309–316
- Wachtel H. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′-5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology 1983; 22: 267–272
- Zeller E., Stief H. J., Pflug B., Sastre-y-Hernández M. Results of a phase II study of the antidepressant effect of rolipram. Pharmacopsychiat 1984; 17: 188–190